This year, many advances in science, medicine and space exploration were introduced to the world, leaving precedents and foundations for continuing development in 2023.
this also includes For the Artemis program of the National Aeronautics and Space Administration (NASA), which brought the world’s attention back to the exploration of the Moonand new methods for the rapid and effective development of vaccines.
This presents some ground for growth in this matter to continue into 2023.
According to the BBC, these are the five advances expected:
New generation vaccines: Success in the development of mRNA-type vaccines to fight the COVID-19 pandemic has allowed the discovery of these antibodies for other viruses and diseases.
This includes such public health problems as malaria, tuberculosis, genital herpes, HIV, cystic fibrosis, cancer and various types of lung diseases.
Such is the case with BioNTech, which began its first trials of a malaria and tuberculosis vaccine. Whereas, Moderna does the same with genital herpes and herpes.
Advanced Space Observation: The precedent in this field was set by the launch of the James Webb Space Telescope, an instrument launched by NASA, the European Space Agency (ESA) and the Canadian Space Agency.
This leads ESA to launch the Euclid telescope in 2023, which aims to enter solar orbit for six years and thus create a 3D map of the universe, while the Japan Aerospace Exploration Agency will collect X-ray radiation from distant stars. and works on a mission to explore the Milky Way.
Chile, in turn, has the Vera C. Rubin Telescope, which has a camera with a resolution of over 3,000 million pixels and will begin capturing images in July.
Mission to the Moon: The initiative here comes from NASA’s Artemis program, which shipped the Orion capsule without people. Well, the United Arab Emirates has already launched its Rashid lunar vehicle on December 11, which will review the lunar surface.
This includes the Hakuto-R module from Japan, whose mission is to land on the moon in April, and Chandrayaan-3 from India, which will attempt to reach the lunar south pole in mid-2023.
Apart from the first civilian flight to the moon, in which 11 people will go on a six-day journey aboard Elon Musk’s SpaceX company’s Starship rocket.
CRISPR Genetic Engineering: Approval is expected next year for CRISPR-Cas9 therapy, a gene editing technique that allows a DNA strand to be altered by cutting out part of it and rearranging it to form a new sequence.
Promising results were seen in clinical trials against two genetic blood disorders, including sickle cell disease.
This approval will be made available to sickle cell anemia patients by Axa-Cell.
Alzheimer’s drugs: As of November 2022, the existence of a drug capable of slowing down the destruction of brains affected by the disease was discovered.
For this reason, in early 2023, US regulators will reveal whether it will be available to treat patients, although it is only effective in the early stages of the disease.
It’s about lecanumab, which attacks the sticky plaque – called beta-amyloid – that accumulates in the brains of people with Alzheimer’s.
This is relevant, as it is considered “the beginning of Alzheimer’s treatment” according to experts.